CA Stock MarketDetailed Quotes
AION Aion Therapeutic Inc
- 0.020
- 0.0000.00%
15min DelayTrading Nov 5 13:50 ET
9.67MMarket Cap-4000P/E (TTM)
0.000High0.000Low0Volume0.000Open0.020Pre Close0.00Turnover0.02052wk High0.00%Turnover Ratio483.55MShares0.00552wk Low-0.005EPS TTM9.02MFloat Cap0.350Historical HighLossP/E (Static)450.98MShs Float0.005Historical Low-0.002EPS LYR0.00%Amplitude--Dividend TTM10.00P/B1Lot Size--Div YieldTTM
Aion Therapeutic Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 303.08%243.24K | -650.30%-43.82K | -190.31%-235.59K | 96.93%-41.4K | 1,205.36%151.57K | -22.17%-119.77K | 102.07%7.96K | 90.74%-81.15K | 36.87%-1.35M | 101.67%11.61K |
| Net income from continuing operations | -75.21%-377.95K | -44.42%-181.36K | -212.02%-328.58K | 93.28%-256.66K | 87.11%-208.67K | 66.85%-215.72K | 84.34%-125.58K | 139.26%293.32K | 53.80%-3.82M | 69.24%-1.62M |
| Operating gains losses | ---- | ---- | ---- | ---563.3K | --135.19K | ---136.24K | --0 | ---562.24K | ---- | ---- |
| Depreciation and amortization | 156.56%14.97K | --0 | --0 | -73.50%17.3K | -92.19%126 | -66.62%5.84K | -74.93%5.79K | -75.98%5.55K | -49.04%65.29K | -93.05%1.61K |
| Asset impairment expenditure | --0 | --0 | --0 | -124.68%-246.84K | ---135.19K | --0 | --0 | ---111.66K | -80.61%1M | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --108.81K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | 13.84%47.75K | -24.23%29.24K | -1.85%34.45K | 110.70%146.76K | 7.95%31.11K | 77.98%41.95K | 143.49%38.6K | 2,391.06%35.1K | -58.54%69.65K | -46.03%28.82K |
| Change In working capital | 202.84%558.47K | 21.48%108.3K | -77.38%58.55K | -43.70%752.53K | -63.30%220.19K | -63.96%184.41K | -76.45%89.15K | 268.33%258.78K | 488.36%1.34M | 332.70%600.01K |
| -Change in receivables | -523.44%-41.37K | 226.02%15.27K | 1,027.01%157.68K | 29.16%-54.89K | -586.30%-19.13K | 69.37%-6.64K | 70.69%-12.11K | -45.23%-17.01K | -3,743.11%-77.49K | 70.11%-2.79K |
| -Change in prepaid assets | --0 | ---1.75K | --0 | -96.35%7.66K | --0 | -19.86%28.91K | --0 | -226.47%-21.26K | 205.52%209.71K | 691.51%160.48K |
| -Change in payables and accrued expense | 290.73%633.5K | 11.89%113.31K | -133.37%-99.13K | -32.61%799.77K | -43.66%239.33K | -67.39%162.13K | -76.10%101.27K | 287.02%297.05K | 180.06%1.19M | 142.58%424.82K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --17.5K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 303.08%243.24K | -650.30%-43.82K | -190.31%-235.59K | 96.93%-41.4K | 1,205.36%151.57K | -22.17%-119.77K | 102.07%7.96K | 90.74%-81.15K | 36.87%-1.35M | 101.67%11.61K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -117.28%-23.36K | -201.28K | -64.78K | 135.19K | 0 | 135.19K | 0 | 0 | 0 | 0 |
| Net PPE purchase and sale | ---- | ---- | ---- | --135.19K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net other investing changes | ---23.36K | ---201.28K | ---64.78K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -117.28%-23.36K | ---201.28K | ---64.78K | --135.19K | --0 | --135.19K | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 139.51%48.71K | 124.18%387.5K | 37.37%155K | -86.37%163.25K | -98.80%860 | -227.38%-123.29K | 194.85%172.85K | -90.68%112.83K | -60.12%1.2M | -89.94%71.5K |
| Net issuance payments of debt | 118.46%22.76K | --0 | --0 | -43.07%63.25K | -98.80%860 | -227.38%-123.29K | 139.98%72.85K | -9.76%112.83K | 140.59%111.09K | 148.09%71.5K |
| Net common stock issuance | --0 | --387.5K | --155K | --0 | --0 | --0 | --0 | --0 | -62.24%1.11M | --0 |
| Net other financing activities | ---- | ---- | ---- | 487.75%100K | --0 | --0 | ---- | ---- | -107.80%-25.79K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 139.51%48.71K | 124.18%387.5K | 37.37%155K | -86.37%163.25K | -98.80%860 | -227.38%-123.29K | -45.61%172.85K | -84.14%112.83K | -60.12%1.2M | -89.94%71.5K |
| Net cash flow | ||||||||||
| Beginning cash position | -93.13%926 | 100.25%33.92K | --336 | --0 | --0 | 27.41%13.47K | -78.34%16.94K | --0 | -60.86%239.83K | -99.29%1.85K |
| Current changes in cash | 348.97%268.58K | -21.24%142.4K | -558.84%-145.36K | 271.85%257.04K | 83.40%152.43K | -8,565.06%-107.88K | 372.36%180.81K | 119.19%31.68K | 70.75%-149.57K | 154.10%83.11K |
| Effect of exchange rate changes | -15.50%79.77K | 4.82%-175.4K | 1,313.93%178.95K | -184.40%-256.7K | -79.00%-152.09K | 1,362.62%94.41K | -14,773.04%-184.28K | -530.90%-14.74K | -165.25%-90.26K | -164.65%-84.96K |
| End cash Position | --349.28K | -93.13%926 | 100.25%33.92K | --336 | --336 | --0 | 27.41%13.47K | -78.34%16.94K | --0 | --0 |
| Free cash from | 303.08%243.24K | -650.30%-43.82K | -190.31%-235.59K | 96.93%-41.4K | 1,205.36%151.57K | -22.17%-119.77K | 102.07%7.96K | 90.74%-81.15K | 62.36%-1.35M | 101.16%11.61K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data